Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: May 27, 2022

CLINICAL TRIALS PROFILE FOR DROSPIRENONE AND ETHINYL ESTRADIOL

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Drospirenone And Ethinyl Estradiol

Subscribe to access the full database, or Try it Free
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00413062 ↗	Efficacy and Safety Study of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292002)(P05722)	Completed	Merck Sharp & Dohme Corp.	Phase 3	2006-06-01	The primary purpose of this study is to assess contraceptive efficacy, vaginal bleeding patterns (cycle control), general safety and acceptability of the nomegestrol acetate-estradiol (NOMAC-E2) combined oral contraceptive (COC) in a large group of women aged 18-50 years.
NCT00511199 ↗	Efficacy and Safety of the Combined Oral Contraceptive (COC) NOMAC-E2 Compared to a COC Containing DRSP/EE (292001)(COMPLETED)(P05724)	Completed	Merck Sharp & Dohme Corp.	Phase 3	2006-05-01	The primary purpose of this study is to assess contraceptive efficacy, vaginal bleeding patterns (cycle control), general safety and acceptability of the nomegestrol acetate-estradiol (NOMAC-E2) combined oral contraceptive (COC) in a large group of women aged 18-50 years.
NCT00511433 ↗	Effects on Ovarian Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292003)(COMPLETED)(P05723)	Completed	Merck Sharp & Dohme Corp.	Phase 3	2006-10-01	The primary purpose of this study is to evaluate the effects of the nomegestrol acetate-estradiol (NOMAC-E2) combined oral contraceptive (COC) on ovarian function.
NCT00567164 ↗	Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ	Completed	Bayer	Phase 3	2007-10-01	The purpose of this study is to determine whether the study drug is safe and effective.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Drospirenone And Ethinyl Estradiol

Condition Name

Chart
Table

Condition Name for Drospirenone And Ethinyl Estradiol
Intervention	Trials
Contraception	10
Polycystic Ovary Syndrome	4
Healthy	4
Acne Vulgaris	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Drospirenone And Ethinyl Estradiol
Intervention	Trials
Polycystic Ovary Syndrome	4
Acne Vulgaris	3
Endometriosis	3
Syndrome	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Drospirenone And Ethinyl Estradiol

Trials by Country

Map
Table

Trials by Country for Drospirenone And Ethinyl Estradiol
Location	Trials
United States	82
China	21
Germany	14
United Kingdom	6
Austria	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Drospirenone And Ethinyl Estradiol
Location	Trials
California	5
Massachusetts	5
Pennsylvania	5
Florida	4
Arizona	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Drospirenone And Ethinyl Estradiol

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Drospirenone And Ethinyl Estradiol
Clinical Trial Phase	Trials
Phase 4	8
Phase 3	15
Phase 2/Phase 3	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Drospirenone And Ethinyl Estradiol
Clinical Trial Phase	Trials
Completed	21
Unknown status	4
Recruiting	2
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Drospirenone And Ethinyl Estradiol

Sponsor Name

Chart
Table

Sponsor Name for Drospirenone And Ethinyl Estradiol
Sponsor	Trials
Bayer	13
Merck Sharp & Dohme Corp.	3
Massachusetts General Hospital	3
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Drospirenone And Ethinyl Estradiol
Sponsor	Trials
Industry	23
Other	14
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter

Boehringer Ingelheim

Merck

Colorcon

AstraZeneca

McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.